texas oncology more breakthroughs. more victories

Dhatri Kodali, M.D.

Dhatri Kodali, M.D. Photo

Provider Type: Physician

Board Certifications:
  • Hematology
  • Internal Medicine
  • Medical Oncology


General Summary

Dr. Kodali joined Texas Oncology in 2008. She treats various cancers including breast, lung, and colon cancer as well as other cancers. In addition, she treats benign and malignant blood disorders such as leukemia and lymphomas. Her philosophy is to empower patients to receive high quality, holistic and compassionate care in their own communities. Her areas of interest include breast cancer, hematological malignancies, cancer genetics, and cancer prevention and survivorship.


Dr. Kodali was awarded medical degree in 1999 from Andhra Medical College in AP, India. She completed her internship and residency in Internal Medicine at St. Vincent Hospital, Massachusetts. Dr. Kodali also received post-doctoral training at Brigham and Women’s Hospital, Boston where she worked in the Weiner Lab. Her clinical rotations took place at Memorial Sloan-Kettering, New York. She earned a master’s degree in clinical research and received her fellowship training in Hematology, Oncology, and Transplantation from the University of Minnesota. She’s a graduate of the advanced course in cancer genetics through the City of Hope, California.

Accolades & Memberships

  • American Medical Association
  • American Society of Clinical Oncology
  • American Society of Hematology
  • Harris County Medical Society

She received a Merit Scholarship from the government of India for scholastic excellence in addition to prize awards in several regional and national meetings in the United States (ACP, ACCP, ASBMT)


  • Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within breast cancer subtypes and stages among older women: a SEER-Medicare analysis.

    Breast Cancer, 2023

  • Neoadjuvant chemotherapy use trends among older women with breast cancer: 2010-2017

    Breast Cancer Res Treat, 2022

  • Germline testing in community oncology patients with somatic BRCA1/2 mutations

    Journal of Clinical Oncology, 2021

  • Expression and Phosphorylation of Eukaryotic Translation Initiation Factor 4E Binding Protein 1 in B-Cell Lymphomas and Reactive Lymphoid Tissues

    Archives of Pathology & Laboratory Medicine, 2011

  • Thrombocytosis in Myelodysplastic and Myelodysplastic/Myeloproliferative Syndromes

    Leukemia & Lymphoma, 2007

Show all Publications
  • Primary Cardiac Angiosarcoma Case Report and Review

    Sarcoma, 2006

  • Adrenergic Shock – An Overlooked Clinical Entity?

    Cardiology in Review, 2005

  • Induction of Low Dose Oral Tolerance in IL-10 Deficient Mice With Experimental Autoimmune Encephalomyelitis

    Journal of Autoimmunity, 2004

  • Induction of Low Dose Oral Tolerance in Monocyte Chemoattractant Protein-1- and CCR2-Deficient Mice

    The Journal of Immunology, 2003

Research Interest

Dhatri Kodali, is a member of the breast committee and hematology committee of the US Oncology Research and conducts clinical research trials at her Webster office. She is also involved in cancer genetics and outcomes research. She has authored in many publications and presented her work at numerous national conferences.

Related Stories

Other Information

Dr Kodali is married and has two children. She lives in Friendswood and in her free time she enjoys traveling and spending time with family. She is involved in outreach activities.